80 related articles for article (PubMed ID: 15918771)
1. Discovery of the antiviral activities of pharmacologic cyclin-dependent kinase inhibitors: from basic to applied science.
Schang LM
Expert Rev Anti Infect Ther; 2005 Apr; 3(2):145-9. PubMed ID: 15918771
[TBL] [Abstract][Full Text] [Related]
2. Cellular proteins (cyclin dependent kinases) as potential targets for antiviral drugs.
Schang LM
Antivir Chem Chemother; 2001; 12 Suppl 1():157-78. PubMed ID: 11594683
[TBL] [Abstract][Full Text] [Related]
3. Five years of progress on cyclin-dependent kinases and other cellular proteins as potential targets for antiviral drugs.
Schang LM; St Vincent MR; Lacasse JJ
Antivir Chem Chemother; 2006; 17(6):293-320. PubMed ID: 17249245
[TBL] [Abstract][Full Text] [Related]
4. Cyclin-dependent kinase inhibitors: useful targets in cell cycle regulation.
Sielecki TM; Boylan JF; Benfield PA; Trainor GL
J Med Chem; 2000 Jan; 43(1):1-18. PubMed ID: 10633033
[No Abstract] [Full Text] [Related]
5. Herpes simplex viruses in antiviral drug discovery.
Schang LM
Curr Pharm Des; 2006; 12(11):1357-70. PubMed ID: 16611120
[TBL] [Abstract][Full Text] [Related]
6. Effects of pharmacological cyclin-dependent kinase inhibitors on viral transcription and replication.
Schang LM
Biochim Biophys Acta; 2004 Mar; 1697(1-2):197-209. PubMed ID: 15023361
[TBL] [Abstract][Full Text] [Related]
7. CDK inhibitors in cancer therapy: what is next?
Malumbres M; Pevarello P; Barbacid M; Bischoff JR
Trends Pharmacol Sci; 2008 Jan; 29(1):16-21. PubMed ID: 18054800
[TBL] [Abstract][Full Text] [Related]
8. Viral and cellular kinases are potential antiviral targets and have a central role in varicella zoster virus pathogenesis.
Moffat JF; McMichael MA; Leisenfelder SA; Taylor SL
Biochim Biophys Acta; 2004 Mar; 1697(1-2):225-31. PubMed ID: 15023363
[TBL] [Abstract][Full Text] [Related]
9. Structure-based discovery and optimization of potential cancer therapeutics targeting the cell cycle.
Thomas MP; McInnes C
IDrugs; 2006 Apr; 9(4):273-8. PubMed ID: 16596481
[TBL] [Abstract][Full Text] [Related]
10. Cyclin-dependent kinases as cellular targets for antiviral drugs.
Schang LM
J Antimicrob Chemother; 2002 Dec; 50(6):779-92. PubMed ID: 12460995
[TBL] [Abstract][Full Text] [Related]
11. Progress in the evaluation of CDK inhibitors as anti-tumor agents.
McInnes C
Drug Discov Today; 2008 Oct; 13(19-20):875-81. PubMed ID: 18639646
[TBL] [Abstract][Full Text] [Related]
12. Advances on cyclin-dependent kinases (CDKs) as novel targets for antiviral drugs.
Schang LM
Curr Drug Targets Infect Disord; 2005 Mar; 5(1):29-37. PubMed ID: 15777196
[TBL] [Abstract][Full Text] [Related]
13. Structure-guided discovery of cyclin-dependent kinase inhibitors.
Fischmann TO; Hruza A; Duca JS; Ramanathan L; Mayhood T; Windsor WT; Le HV; Guzi TJ; Dwyer MP; Paruch K; Doll RJ; Lees E; Parry D; Seghezzi W; Madison V
Biopolymers; 2008 May; 89(5):372-9. PubMed ID: 17937404
[TBL] [Abstract][Full Text] [Related]
14. Rational design of polymerase inhibitors as antiviral drugs.
Oberg B
Antiviral Res; 2006 Sep; 71(2-3):90-5. PubMed ID: 16820225
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issues.
Pei XH; Xiong Y
Oncogene; 2005 Apr; 24(17):2787-95. PubMed ID: 15838515
[TBL] [Abstract][Full Text] [Related]
16. Antiviral drug discovery and development: where chemistry meets with biomedicine.
De Clercq E
Antiviral Res; 2005 Aug; 67(2):56-75. PubMed ID: 16046240
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of 3,5-diaminoindazoles as cyclin-dependent kinase inhibitors.
Lee J; Choi H; Kim KH; Jeong S; Park JW; Baek CS; Lee SH
Bioorg Med Chem Lett; 2008 Apr; 18(7):2292-5. PubMed ID: 18353638
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of cell cycle blockage of hepatoma SK-Hep-1 cells by Epimedin C through suppression of mitogen-activated protein kinase activation and increased expression of CDK inhibitors p21(Cip1) and p27(Kip1).
Liu TZ; Chen CY; Yiin SJ; Chen CH; Cheng JT; Shih MK; Wang YS; Chern CL
Food Chem Toxicol; 2006 Feb; 44(2):227-35. PubMed ID: 16112786
[TBL] [Abstract][Full Text] [Related]
19. Imidazole piperazines: SAR and development of a potent class of cyclin-dependent kinase inhibitors with a novel binding mode.
Finlay MR; Acton DG; Andrews DM; Barker AJ; Dennis M; Fisher E; Graham MA; Green CP; Heaton DW; Karoutchi G; Loddick SA; Morgentin R; Roberts A; Tucker JA; Weir HM
Bioorg Med Chem Lett; 2008 Aug; 18(15):4442-6. PubMed ID: 18617397
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibitors of picornavirus replication.
De Palma AM; Vliegen I; De Clercq E; Neyts J
Med Res Rev; 2008 Nov; 28(6):823-84. PubMed ID: 18381747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
